ABOUT US

UbiCARE is a public research team led by Dr Manuel S. Rodriguez based in Toulouse, France.

Our group studies processes regulated by members of the ubiquitin family (UbLs) implicated in multiple diseases including infections, neurodegenerative diseases or cancer. We focus on understanding the role of these post-translational modifications (PTM) in the response to actual chemotherapy treatments, identifying the most important events and molecules implicated in the acquisition of resistance to chemotherapy and evaluating the potential of some of them as biomarkers or drug targets.

RESEARCH

Our team focuses on the crosstalk between Ub and UbL proteins in the proteotoxic and genotoxic stress responses.

INNOVATION

We develop technology to explore these responses. Our molecular traps to capture proteins modified by Ub and SUMO are already on the market (TUBEs and SUBEs).

COOPERATION

We value collaboration with both the academic and the private sectors. We are therefore involved in several research networks.

THEY SUPPORT US

Research is formalized curiosity. It is poking and prying with a purpose. It is a seeking that he who wishes may know the cosmic secrets of the world and they that dwell therein.

Zora Neale Hurston | Dust Tracks on a Road (1942)

SOME NUMBERS

%

INTERNATIONAL TEAM MEMBERS

EUROPEAN NETWORKS

%

FOREIGN COLLABORATIONS

MEET THE TEAM

We take up challenges by fusing technical expertise, scientific innovation and creativity.

Manuel Rodriguez
CNRS Research Director
Grégoire Quinet
PhD student MESRI
Maria Gonzalez Santamarta
MSCA PhD student UbiCODE
Rosa Lopez Reyes
PhD student CONACYT
Clémence Coutelle-Rebut
European Project Manager
Clara Louche
Research engineer

© Icons made by Freepik from Flaticon

Webmaster : Clémence Coutelle-Rebut